vs
AerSale Corp（ASLE）与PTC THERAPEUTICS, INC.（PTCT）财务数据对比。点击上方公司名可切换其他公司
PTC THERAPEUTICS, INC.的季度营收约是AerSale Corp的1.8倍（$164.7M vs $90.9M），AerSale Corp净利率更高（5.9% vs -82.0%，领先87.9%），AerSale Corp同比增速更快（-4.0% vs -22.7%），AerSale Corp自由现金流更多（$9.8M vs $-36.6M），过去两年AerSale Corp的营收复合增速更高（0.2% vs -11.5%）
AerSale Corp总部位于美国佛罗里达州多拉市，是一家面向航空领域的全球供应商，主要为客运及货运航空公司、政府机构、跨国整机制造商与独立维修机构提供商用喷气飞机二手整机、发动机、航空耗材，并提供航空工程服务，同时该公司也是飞机机队回收协会的成员企业。
PTC Therapeutics是一家总部位于美国的制药企业，专注于开发口服小分子药物及基因疗法，通过靶向转录后调控机制调节基因表达，相关产品管线主要面向罕见病治疗领域，致力于满足相关疾病未被覆盖的临床治疗需求。
ASLE vs PTCT — 直观对比
营收规模更大
PTCT
是对方的1.8倍
$90.9M
营收增速更快
ASLE
高出18.7%
-22.7%
净利率更高
ASLE
高出87.9%
-82.0%
自由现金流更多
ASLE
多$46.4M
$-36.6M
两年增速更快
ASLE
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $90.9M | $164.7M |
| 净利润 | $5.4M | $-135.0M |
| 毛利率 | 34.1% | — |
| 营业利润率 | 7.8% | -43.3% |
| 净利率 | 5.9% | -82.0% |
| 营收同比 | -4.0% | -22.7% |
| 净利润同比 | 99.7% | -104.8% |
| 每股收益（稀释后） | $0.10 | $-1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASLEPTCT
| Q4 25 | $90.9M | $164.7M | ||
| Q3 25 | $71.2M | $211.0M | ||
| Q2 25 | $107.4M | $178.9M | ||
| Q1 25 | $65.8M | $1.2B | ||
| Q4 24 | $94.7M | $213.2M | ||
| Q3 24 | $82.7M | $196.8M | ||
| Q2 24 | $77.1M | $186.7M | ||
| Q1 24 | $90.5M | $210.1M |
净利润ASLEPTCT
| Q4 25 | $5.4M | $-135.0M | ||
| Q3 25 | $-120.0K | $15.9M | ||
| Q2 25 | $8.6M | $-64.8M | ||
| Q1 25 | $-5.3M | $866.6M | ||
| Q4 24 | $2.7M | $-65.9M | ||
| Q3 24 | $509.0K | $-106.7M | ||
| Q2 24 | $-3.6M | $-99.2M | ||
| Q1 24 | $6.3M | $-91.6M |
毛利率ASLEPTCT
| Q4 25 | 34.1% | — | ||
| Q3 25 | 30.2% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 27.3% | — | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 31.8% | — |
营业利润率ASLEPTCT
| Q4 25 | 7.8% | -43.3% | ||
| Q3 25 | 4.0% | 1.4% | ||
| Q2 25 | 11.7% | -19.5% | ||
| Q1 25 | -10.1% | 82.5% | ||
| Q4 24 | 5.2% | -76.2% | ||
| Q3 24 | 2.4% | -27.7% | ||
| Q2 24 | -2.4% | -21.5% | ||
| Q1 24 | 5.2% | -21.6% |
净利率ASLEPTCT
| Q4 25 | 5.9% | -82.0% | ||
| Q3 25 | -0.2% | 7.5% | ||
| Q2 25 | 8.0% | -36.3% | ||
| Q1 25 | -8.0% | 73.7% | ||
| Q4 24 | 2.9% | -30.9% | ||
| Q3 24 | 0.6% | -54.2% | ||
| Q2 24 | -4.7% | -53.1% | ||
| Q1 24 | 6.9% | -43.6% |
每股收益（稀释后）ASLEPTCT
| Q4 25 | $0.10 | $-1.63 | ||
| Q3 25 | $0.00 | $0.20 | ||
| Q2 25 | $0.18 | $-0.83 | ||
| Q1 25 | $-0.10 | $10.04 | ||
| Q4 24 | $0.05 | $-0.85 | ||
| Q3 24 | $0.01 | $-1.39 | ||
| Q2 24 | $-0.07 | $-1.29 | ||
| Q1 24 | $0.12 | $-1.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.4M | $1.9B |
| 总债务越低越好 | $1.3M | — |
| 股东权益账面价值 | $424.4M | $-205.3M |
| 总资产 | $640.5M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资ASLEPTCT
| Q4 25 | $4.4M | $1.9B | ||
| Q3 25 | $5.3M | $1.7B | ||
| Q2 25 | $5.7M | $2.0B | ||
| Q1 25 | $4.7M | $2.0B | ||
| Q4 24 | $4.7M | $1.1B | ||
| Q3 24 | $9.8M | $1.0B | ||
| Q2 24 | $4.3M | $1.1B | ||
| Q1 24 | $2.6M | $884.8M |
总债务ASLEPTCT
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
股东权益ASLEPTCT
| Q4 25 | $424.4M | $-205.3M | ||
| Q3 25 | $417.1M | $-155.8M | ||
| Q2 25 | $415.9M | $-206.5M | ||
| Q1 25 | $406.5M | $-185.8M | ||
| Q4 24 | $455.6M | $-1.1B | ||
| Q3 24 | $451.5M | $-1.1B | ||
| Q2 24 | $449.8M | $-980.2M | ||
| Q1 24 | $452.0M | $-893.9M |
总资产ASLEPTCT
| Q4 25 | $640.5M | $2.9B | ||
| Q3 25 | $646.3M | $2.6B | ||
| Q2 25 | $646.7M | $2.6B | ||
| Q1 25 | $646.1M | $2.7B | ||
| Q4 24 | $604.7M | $1.7B | ||
| Q3 24 | $601.5M | $1.8B | ||
| Q2 24 | $598.7M | $1.9B | ||
| Q1 24 | $571.7M | $1.8B |
负债/权益比ASLEPTCT
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.4M | $-34.3M |
| 自由现金流经营现金流 - 资本支出 | $9.8M | $-36.6M |
| 自由现金流率自由现金流/营收 | 10.8% | -22.3% |
| 资本支出强度资本支出/营收 | 1.7% | 1.4% |
| 现金转化率经营现金流/净利润 | 2.11× | — |
| 过去12个月自由现金流最近4个季度 | $-29.1M | $702.3M |
8季度趋势，按日历期对齐
经营现金流ASLEPTCT
| Q4 25 | $11.4M | $-34.3M | ||
| Q3 25 | $-8.9M | $-66.3M | ||
| Q2 25 | $19.8M | $-58.3M | ||
| Q1 25 | $-45.2M | $870.1M | ||
| Q4 24 | $37.5M | $-30.0M | ||
| Q3 24 | $10.4M | $-77.0M | ||
| Q2 24 | $-15.3M | $-71.5M | ||
| Q1 24 | $-21.5M | $70.8M |
自由现金流ASLEPTCT
| Q4 25 | $9.8M | $-36.6M | ||
| Q3 25 | $-9.8M | $-69.7M | ||
| Q2 25 | $18.6M | $-59.6M | ||
| Q1 25 | $-47.6M | $868.4M | ||
| Q4 24 | $32.3M | $-33.8M | ||
| Q3 24 | $8.9M | $-77.5M | ||
| Q2 24 | $-18.9M | $-78.8M | ||
| Q1 24 | $-25.0M | $61.2M |
自由现金流率ASLEPTCT
| Q4 25 | 10.8% | -22.3% | ||
| Q3 25 | -13.8% | -33.1% | ||
| Q2 25 | 17.3% | -33.3% | ||
| Q1 25 | -72.4% | 73.8% | ||
| Q4 24 | 34.0% | -15.8% | ||
| Q3 24 | 10.7% | -39.4% | ||
| Q2 24 | -24.6% | -42.2% | ||
| Q1 24 | -27.7% | 29.1% |
资本支出强度ASLEPTCT
| Q4 25 | 1.7% | 1.4% | ||
| Q3 25 | 1.3% | 1.6% | ||
| Q2 25 | 1.1% | 0.7% | ||
| Q1 25 | 3.7% | 0.1% | ||
| Q4 24 | 5.6% | 1.8% | ||
| Q3 24 | 1.9% | 0.3% | ||
| Q2 24 | 4.7% | 4.0% | ||
| Q1 24 | 3.9% | 4.6% |
现金转化率ASLEPTCT
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
PTCT
暂无分部数据
